Zentalis Pharmaceuticals, Inc. Public Float
Zentalis Pharmaceuticals, Inc. (ZNTL) had Public Float of $66.90 million as of 2025-06-30, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-26
- 2025-06-30: Entity Public Float $66.90M.
- 2024-06-28: Entity Public Float $231.60M.
- 2023-06-30: Entity Public Float $1.56B.
- 2022-06-30: Entity Public Float $1.30B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $66.90M 10-K · filed 2026-03-26 |
| 2024-06-28 | $231.60M 10-K · filed 2025-03-26 |
| 2023-06-30 | $1.56B 10-K · filed 2024-02-27 |
| 2022-06-30 | $1.30B 10-K · filed 2023-03-01 |
| 2021-06-30 | $1.76B 10-K/A · filed 2022-10-31 |
| 2020-06-30 | $1.15B 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |